The outcome of relapsed/refractory hodgkin's lymphoma patients post autologous bone marrow transplantation in a Baghdad Medical City Complex Center

The outcome of relapsed/refractory hodgkin's lymphoma patients post autologous bone marrow transplantation in a Baghdad Medical City Complex Center

BACKGROUND: Early autologous hemopoietic stem cell transplant is the best option for treatment of relapsed or refractory Hodgkin lymphoma (HL), which is the standard of care at the time being. The aim of this study was to evaluate the outcome of patients with relapsed/refractory (R/R) HL who receive...

Full description

Bibliographic Details
Main Authors: Maryam Abdhlkadhum, Ali Muhammed Jawad Almothaffar, Mazin Abbas Shubbar, Fawaz Salim Yousif, Zena Albakri
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Iraqi Journal of Hematology
Subjects:
bone marrow transplantation
medical city complex
outcome
relapsed hodgkin lymphoma
Online Access:http://www.ijhonline.org/article.asp?issn=2072-8069;year=2021;volume=10;issue=1;spage=69;epage=74;aulast=Abdhlkadhum

Internet

http://www.ijhonline.org/article.asp?issn=2072-8069;year=2021;volume=10;issue=1;spage=69;epage=74;aulast=Abdhlkadhum

Similar Items